Prebiotic intervention with HAMSAB in untreated essential hypertensive patients: a phase II randomized trial (94039)
Hamdi Jama
1
,
Dakota Rhys-Jones
1
,
Michael Nakai
1
,
CK Yao
1
,
Rachel E Climie
2
,
Yusuke Sata
3
,
Dovile Anderson
4
,
Darren J Creek
4
,
Geoffrey A Head
3
,
David M Kaye
3
,
Charles R Mackay
1
,
Jane Muir
1
,
Francine Z Marques
1
- Monash University, Melbourne, VICTORIA, Australia
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
- Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
- Monash Institute of Pharmaceutical Sciences, , Monash University, Melbourne, Victoria, Australia